(NYSE: GSK) Gsk's forecast annual revenue growth rate of 3.53% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 10.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.7%.
Gsk's revenue in 2025 is $40,663,636,363.On average, 3 Wall Street analysts forecast GSK's revenue for 2025 to be $164,247,637,130,000, with the lowest GSK revenue forecast at $158,939,617,800,000, and the highest GSK revenue forecast at $166,975,411,300,000. On average, 3 Wall Street analysts forecast GSK's revenue for 2026 to be $173,981,328,065,000, with the lowest GSK revenue forecast at $172,691,582,600,000, and the highest GSK revenue forecast at $175,310,179,950,000.
In 2027, GSK is forecast to generate $182,510,886,750,000 in revenue, with the lowest revenue forecast at $182,510,886,750,000 and the highest revenue forecast at $182,510,886,750,000.